Product Information
ROBAFEN DM 200-20 MG/20 ML LIQ is a generic product labeled by Major Pharmaceuticals, priced at $0.0207 per ML under NDC 00904744120. Its NADAC has been published 93 times since Dec 25, 2024.
Strength
20; 200 mg/20mL; mg/20mL
Manufacturer
Major PharmaceuticalsNDC
00904744120
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/5/2024
Pharmacological Classes
Price Statistics
The NADAC for ROBAFEN DM 200-20 MG/20 ML LIQ has been published 93 times since Dec 25, 2024, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0207 per ML |
|---|---|
| All-time high | $0.0207 (Sep 30, 2026) |
| All-time low | $0.0187 (Dec 25, 2024) |
| 52-week high | $0.0207 |
| 52-week low | $0.0197 |
| Median price | $0.0201 |
| Average price | $0.0198 |
| Largest weekly change | -3.8% (Apr 23, 2025) |
| Weeks tracked | 93 |
| Tracking since | Dec 25, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROBAFEN DM 200-20 MG/20 ML LIQ?
The current National Average Drug Acquisition Cost (NADAC) for ROBAFEN DM 200-20 MG/20 ML LIQ, manufactured by Major Pharmaceuticals, is $0.0207 per ML (NDC 00904744120), effective Sep 30, 2026.
How has the price of ROBAFEN DM 200-20 MG/20 ML LIQ changed over time?
Over the history we have for it, the NADAC for ROBAFEN DM 200-20 MG/20 ML LIQ has risen 10.9%. It has been tracked across 93 weekly CMS publications since Dec 25, 2024.
What are the highest and lowest recorded NADAC prices for ROBAFEN DM 200-20 MG/20 ML LIQ?
Since Dec 25, 2024, the NADAC for ROBAFEN DM 200-20 MG/20 ML LIQ has ranged from a low of $0.0187 (Dec 25, 2024) to a high of $0.0207 (Sep 30, 2026), with a median of $0.0201 per ML.
Are there cheaper alternatives to ROBAFEN DM 200-20 MG/20 ML LIQ?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GNP TUSSIN DM 200-20 MG/20 ML, is $0.0148 per ML — about 29% below ROBAFEN DM 200-20 MG/20 ML LIQ.
Who manufactures ROBAFEN DM 200-20 MG/20 ML LIQ?
ROBAFEN DM 200-20 MG/20 ML LIQ (NDC 00904744120) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.